Wayland Group Corp - Ordinary Shares

Wayland Group Corp - Ordinary Shares

Wayland is a global leader in providing quality cannabis derived non-medical and medical products.
Medical Resources
1d 5d 1m 6m 1y Max
1d 5d 1m 6m 1y Max

Wayland Group Corp - Ordinary Shares News

30 May

Wayland Group Closes Transaction with ICC International Cannabis Corp.

Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that the Company has completed a transaction relating to the sale of a 49.9% interest in Maricann B.V. (“Wayland...

24 May

Wayland Group provides Clarification on ICC Transaction

The Company understands that ICC International Cannabis Corp. will retract the erroneous announcement on this subject that was made early today. Wayland is a vertically integrated cultivator and processor...

21 May

Wayland Group Confirms “BfARM” award for German Cannabis production

DEMECAN is awarded three lots of thirteen total, which makes DEMECAN one of three companies globally to achieve a cannabis license for domestic production in Germany, out of 79 applicants. DEMECAN will...

02 May

Wayland Addresses Transaction with ICC International Cannabis Corp.

Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) confirms that any failure-to-file cease trade order (“FFCTO”) derived from the Company’s delay in annual filings will not materially...

30 Apr

Wayland Group Confirms Delay in Annual Filings; Expects Issuance of Cease Trade Order

Wayland Group Corp. (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) announced today that it will be delayed in filing its audited annual financial statements for the year ended December 31, 2018,...

23 Apr

Wayland Group Announces Anticipated Delay in Annual Filings

Wayland Group Corp. (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) announced today that it anticipates a delay in filing its audited annual financial statements for the year ended December 31,...

23 Apr

REPEAT - Wayland Group Signs Definitive Agreement with ICC International Cannabis Corp. to Sell 49.9% of In

Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that the Company has signed a definitive agreement to sell a 49.9% interest in Wayland’s international portfolio...

23 Apr

REPEAT - International Cannabis Signs Definitive Agreement to Acquire 49.9% of International Asset and Lice

ICC International Cannabis Corp. (CSE:WRLD.U)(8K51.F)(WLDCF) ("ICC" or “International Cannabis” the “Company”) is pleased to announce that the Company has signed a definitive agreement to acquire 49.9%...

23 Apr

Wayland Group Signs Definitive Agreement with ICC International Cannabis Corp. to Sell 49.9% of Internation

Wayland Group (CSE:WAYL) (75M.F) (MRRCF) (“Wayland” or the “Company”) is pleased to announce that the Company has signed a definitive agreement to sell a 49.9% interest in Wayland’s international portfolio...

23 Apr

International Cannabis Signs Definitive Agreement to Acquire 49.9% of International Asset and Licence Portf

ICC International Cannabis Corp. (CSE:WRLD.U)(8K51.F)(WLDCF) ("ICC" or “International Cannabis” the “Company”) is pleased to announce that the Company has signed a definitive agreement to acquire 49.9%...

Load more

About Wayland Group Corp - Ordinary Shares

Wayland Group Corporation, formerly Maricann, was founded in 2013 and is based in a well-established agricultural region in southwestern Ontario, Canada. In March of 2014 Wayland earned a Health Canada license to cultivate plants and in December earned a license from Health Canada to sell dried flower.

The company sold $1.97mm dried cannabis in 2015. In 2016, the company purchased 97.5 contiguous acres while earning a license to sell cannabis extracts. Wayland is partnered with Evolab, its Colorado-based extraction technology partner, to access its leading technology and processes.

Wayland grows all-natural plants in its energy-efficient greenhouse, while maintaining secure and consistent supply, as it has focused on eight profitable and proven strains and is aiming for production costs of $1.34 per gram.

Wayland is currently expanding domestic and international capacity and distribution channels. In Germany, the company has commenced a retrofit of a 500,000 square-foot cultivation facility and is preparing to cultivate all-natural plants in a portion of the facility in Dresden. The company raised $40mm by way of private placement in 2018.

$ 0.13
-4.48%
Open:
0.13
High:
0.13
Low:
0.09
Share volume:
100.362 K
Total value:
59.607 K
Market cap:
128.089 M
Symbol:
MRRCF